Dr. Jian Li 李剑
Chief Physician
Department of General Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for gastrointestinal tumors, sphincter-preserving surgery for very low rectal cancer, totally laparoscopic radical gastrectomy, and no-incision radical colectomy (NOSES).
Dr. Li holds a medical doctorate and serves as Chief Physician. Clinical expertise includes minimally invasive surgery for gastrointestinal tumors, sphincter-preserving surgery for very low rectal cancer, totally laparoscopic radical gastrectomy, and no-incision radical colectomy (NOSES).
Name order: in Chinese the family name comes first (Li Jian). Papers usually list the name as Jian Li or Li J.
Selected publications
32 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lancet Gastroenterol Hepatol, 2026 (first author): Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRAS(G12C) mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials. PubMed 41344351
- Cancer Commun (Lond), 2025 (first author): Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials. PubMed 41037823
- Clin Colorectal Cancer, 2025 (first author): Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 Study. PubMed 39632230
- Oncologist, 2024 (first author): A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice. PubMed 38642091
- Int J Biol Sci, 2024 (senior author): METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts. PubMed 39247832
- Chin J Cancer Res, 2024 (first author): Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors. PubMed 38988490
- Int J Nanomedicine, 2024 (senior author): TiO(2)-Ti(3)C(2) Nanocomposites Utilize Their Photothermal Activity for Targeted Treatment of Colorectal Cancer. PubMed 38317849
- Zhonghua Wei Chang Wai Ke Za Zhi, 2012 (first author): [Association of early diarrhea after the low anterior resection of rectal cancer and anastomotic leakage]. PubMed 22539380
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion